MutsaersS.E., BishopJ.E., McGroutherG., LaurentG.J.Mechanisms of tissue repair: From wound healing to fibrosis.Int J Biochem Cell Biol1997; 29: 5–17.
2.
BorderW.A., OkudaS., LanguinoL.R., SpornM.B., RuoslahtiE.Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.Nature1990; 346: 371–4.
3.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
4.
MateijsenM.A., van der WalA.C., HendriksP.M., ZweersM.M., MulderJ., StruijkD.G.Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.Perit Dial Int1999; 19: 517–25.
5.
PlumJ., HermannS., FusshollerA., SchoenickeG., DonnerA., RohrbornA.Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.Kidney Int Suppl2001; 78: S42–7.
6.
JonassonP., BraideM.A commercially available PD fluid with high pH and low GDP induces different morphological changes of rat peritoneum in intermittent PD.Adv Perit Dial1998; 14: 48–53.
7.
HaH., YuM.R., LeeH.B.High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.Kidney Int2001; 59: 463–70.
8.
KangD.H., HongY.S., LimH.J., ChoiJ.H., HanD.S., YoonK.I.High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: Effect of cytokine costimulation.Perit Dial Int1999; 19: 221–30.
9.
NaikiY., MaedaY., MatsuoK., YonekawaS., SakaguchiM., IwamotoI.Involvement of TGF-β signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.J Nephrol2003; 16: 95–102.
10.
DevuystO., TopleyN., WilliamsJ.D.Morphological and functional changes in the dialysed peritoneal cavity: Impact of more biocompatible solutions.Nephrol Dial Transplant2002; 17(Suppl 3): 12–15.
11.
WitowskiJ., WisniewskaJ., KorybalskaK., BenderT.O., BreborowiczA., GahlG.M.Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.J Am Soc Nephrol2001; 12: 2434–41.
12.
TauerA., KnerrT., NiwaT., SchaubT.P., LageC., Passlick–DeetjenJ.In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis.Biochem Biophys Res Commun2001; 280: 1408–14.
13.
DevuystO.New insights in the molecular mechanisms regulating peritoneal permeability.Nephrol Dial Transplant2002; 17: 548–51.
14.
BoulangerE., WautierM.P., WautierJ.L., BovalB., PanisY., WernertN.AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.Kidney Int2002; 61: 148–56.
15.
KimY.S., KimB.C., SongC.Y., HongH.K., MoonK.C., LeeH.S.Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.J Lab Clin Med2001; 138: 59–68.
16.
LambE.J., CattellW.R., DawnayA.B.In vitro formation of advanced glycation end products in peritoneal dialysis fluid.Kidney Int1995; 47: 1768–74.
17.
FriedlanderM.A., WuY.C., ElgawishA., MonnierV.M.Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.J Clin Invest1996; 97: 728–35.
18.
Ho-dac-PannekeetM.M., WeissM.F., de WaartD.R., ErhardP., HiralallJ.K., KredietR.T.Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.Perit Dial Int1999; 19(Suppl 2): S68–74.
19.
NakamuraS., MiyazakiS., SakaiS., MoritaT., HirasawaY., NiwaT.Localization of imidazolone in the peritoneum of capd patients: A factor for a loss of ultrafiltration.Am J Kidney Dis2001; 38(Suppl 1): S107–10.
20.
HondaK., NittaK., HoritaS., YumuraW., NiheiH., NagaiR.Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.Nephrol Dial Transplant1999; 14: 1541–9.
21.
ParkM.S., LeeH.A., ChuW.S., YangD.H., HwangS.D.Peritoneal accumulation of AGE and peritoneal membrane permeability.Perit Dial Int2000; 20: 452–60.
22.
CombetS., MiyataT., MoulinP., PouthierD., GoffinE., DevuystO.Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis.J Am Soc Nephrol2000; 11: 717–28.
23.
InagiR., MiyataT., YamamotoT., SuzukiD., UrakamiK., SaitoA.Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis.FEBS Lett1999; 463: 260–4.
24.
TopleyN., LiberekT., DavenportA., LiF.K., FearH., WilliamsJ.D.Activation of inflammation and leukocyte recruitment into the peritoneal cavity.Kidney Int Suppl1996; 56: S17–21.
LaiK.N., LaiK.B., LamC.W., ChanT.M., LiF.K., LeungJ.C.Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis2000; 35: 644–52.
27.
MlamboN.C., HylanderB., BraunerA.Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: A study during non-infected steady state and peritonitis.Inflammation1999; 23: 131–9.
28.
MargettsP.J., KolbM., YuL., HoffC.M., HolmesC.J., AnthonyD.C.Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.Am J Pathol2002; 160: 2285–94.
29.
YangW.S., KimB.S., LeeS.K., ParkJ.S., KimS.B.Interleukin-1β stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells.Perit Dial Int1999; 19: 211–20.
30.
Mandl–WeberS., HaslingerB., LedererS.R., SitterT.Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: Role of interleukin-1alpha.Am J Kidney Dis2001; 37: 815–19.
31.
VisserC.E., Brouwer–SteenbergenJ.J., StruijkG., KredietR.T., BeelenR.H.Production of IL-1 beta and TNF-alpha by peritoneal macrophages depends on the bacterial species and the inoculum.Adv Perit Dial1997; 13: 201–4.
32.
MiyataT., van YperseleD.S., KurokawaK., BaynesJ.W.Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications.Kidney Int1999; 55: 389–99.
33.
CombetS., FerrierM.L., Van LandschootM., StoenoiuM., MoulinP., MiyataT.Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum.J Am Soc Nephrol2001; 12: 2146–57.
34.
StenvinkelP., HeimburgerO., PaultreF., DiczfalusyU., WangT., BerglundL.Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.Kidney Int1999; 55: 1899–911.
35.
StenvinkelP., ChungS.H., HeimburgerO., LindholmB.Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients.Perit Dial Int2001; 21(Suppl 3): S157–62.
36.
MargettsP.J., KolbM., GaltT., HoffC.M., ShockleyT.R., GauldieJ.Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function.J Am Soc Nephrol2001; 12: 2029–39.
Iglesias–De La CruzM.C., ZiyadehF.N., IsonoM., KouahouM., HanD.C., KalluriR.Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.Kidney Int2002; 62: 901–13.
39.
RougierJ.P., GuiaS., HagegeJ., NguyenG., RoncoP.M.PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: Transcriptional regulation by TGF-beta 1.Kidney Int1998; 54: 87–98.
40.
MartinJ., YungS., RobsonR.L., SteadmanR., DaviesM.Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells.Perit Dial Int2000; 20: 524–33.
DennlerS., GoumansM.J., ten DijkeP.Transforming growth factor beta signal transduction.J Leukoc Biol2002; 71: 731–40.
43.
MoustakasA., PardaliK., GaalA., HeldinC.H.Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation.Immunol Lett2002; 82: 85–91.
AttisanoL., WranaJ.L.Signal transduction by the TGF-beta superfamily.Science2002; 296: 1646–7.
47.
KolbM., MargettsP.J., SimeP.J., GauldieJ.Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.Am J Physiol Lung Cell Mol Physiol2001; 280: L1327–L1334.
48.
AbreuJ.G., KetpuraN.I., ReversadeB., De RobertisE.M.Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.Nat Cell Biol2002; 4: 599–604.
49.
LinC.Y., ChenW.P., FuL.W., YangL.Y., HuangT.P.Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.Adv Perit Dial1997; 13: 64–71.
50.
LaiK.N., LaiK.B., SzetoC.C., LamC.W., LeungJ.C.Growth factors in continuous ambulatory peritoneal dialysis effluent. Their relation with peritoneal transport of small solutes.Am J Nephrol1999; 19: 416–22.
51.
ZweersM.M., de WaartD.R., SmitW., StruijkD.G., KredietR.T.Growth factors VEGF and TGF-beta1 in peritoneal dialysis. [see Comments.] J Lab Clin Med1999; 134: 124–32.
52.
CombetS., Van LandschootM., MoulinP., PiechA., VerbavatzJ.M., GoffinE.Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis.J Am Soc Nephrol1999; 10: 2185–96.
53.
FerrierM.L., CombetS., Van LandschootM., StoenoiuM.S., CnopsY., LameireN.Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis.Kidney Int2001; 60: 2343–50.
54.
WitteM.B., BarbulA.Role of nitric oxide in wound repair.Am J Surg2002; 183: 406–12.
55.
FerriniM.G., VernetD., MageeT.R., ShahedA., QianA., RajferJ.Antifibrotic role of inducible nitric oxide synthase.Nitric Oxide2002; 6: 283–94.
56.
MoussadE.E., BrigstockD.R.Connective tissue growth factor: What's in a name?Mol Genet Metab2000; 71: 276–92.
57.
EddyA.A.Plasminogen activator inhibitor-1 and the kidney.Am J Physiol Renal Physiol2002; 283: F209–F220.
58.
PowellD.W., MifflinR.C., ValentichJ.D., CroweS.E., SaadaJ.I., WestA.B.Myofibroblasts. I. Paracrine cells important in health and disease.Am J Physiol1999; 277: C1–C9.
59.
GauldieJ., SimeP.J., XingZ., MarrB., TremblayG.M.Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis.Curr Top Pathol1999; 93: 35–45.
60.
LaneA., JohnsonD.W., PatB., WinterfordC., EndreZ., WeiM.Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis.Growth Factors2002; 20: 109–19.
61.
Yanez-MoM., Lara-PezziE., SelgasR., Ramirez-HuescaM., Dominguez-JimenezC., Jimenez-HeffernanJ.A.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
62.
TomasekJ.J., GabbianiG., HinzB., ChaponnierC., BrownR.A.Myofibroblasts and mechano-regulation of connective tissue remodelling.Nat Rev Mol Cell Biol2002; 3: 349–63.
63.
GabbianiG.The cellular derivation and the life span of the myofibroblast.Pathol Res Pract1996; 192: 708–11.
64.
SundbergC., IvarssonM., GerdinB., RubinK.Pericytes as collagen-producing cells in excessive dermal scarring.Lab Invest1996; 74: 452–66.
65.
WilcoxJ.N., OkamotoE.I., NakaharaK.I., Vinten–JohansenJ.Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: A role for circulating myofibroblast precursors?Ann NY Acad Sci2001; 947: 68–90.
66.
IwanoM., PliethD., DanoffT.M., XueC., OkadaH., NeilsonE.G.Evidence that fibroblasts derive from epithelium during tissue fibrosis.J Clin Invest2002; 110: 341–50.
67.
YangA.H., ChenJ.Y., LinJ.K.Myofibroblastic conversion of mesothelial cells.Kidney Int2003; 63: 1530–9.
68.
SavagnerP.Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition.Bioessays2001; 23: 912–23.
69.
CamenischT.D., MolinD.G., PersonA., RunyanR.B., Gittenberger–de GrootA.C., McDonaldJ.A.Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis.Dev Biol2002; 248: 170–81.
70.
PiekE., MoustakasA., KurisakiA., HeldinC.H., ten DijkeP.TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.J Cell Sci1999; 112(Pt 24): 4557–68.
71.
RastaldiM.P., FerrarioF., GiardinoL., Dell'AntonioG., GrilloC., GrilloP.Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.Kidney Int2002; 62: 137–46.
YangJ., LiuY.Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.Am J Pathol2001; 159: 1465–75.
74.
PaganR., SanchezA., MartinI., LloberaM., FabregatI., VilaroS.Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes.J Hepatol1999; 31: 895–904.
75.
BoyerB., VallesA.M., EdmeN.Induction and regulation of epithelial-mesenchymal transitions.Biochem Pharmacol2000; 60: 1091–9.
76.
CarverE.A., JiangR., LanY., OramK.F., GridleyT.The mouse Snail gene encodes a key regulator of the epithelial-mesenchymal transition.Mol Cell Biol2001; 21: 8184–8.
77.
KaibuchiK., KurodaS., AmanoM.Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.Annu Rev Biochem1999; 68: 459–86.
BrooksP.C., StrombladS., SandersL.C., von SchalschaT.L., AimesR.T., Stetler–StevensonW.G.Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.Cell1996; 85: 683–93.
83.
BrooksP.C., MontgomeryA.M., RosenfeldM., ReisfeldR.A., HuT., KlierG.Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.Cell1994; 79: 1157–64.
84.
TurckJ., PollockA.S., LovettD.H.Gelatinase A is a glomerular mesangial cell growth and differentiation factor.Kidney Int1997; 51: 1397–400.
85.
TurckJ., PollockA.S., LeeL.K., MartiH.P., LovettD.H.Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation.J Biol Chem1996; 271: 15074–83.
86.
MatsumotoK., NakamuraT.Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases.Kidney Int2001; 59: 2023–38.
87.
RampinoT., CancariniG., GregoriniM., GualliniP., MaggioM., RanghinoA.Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells.Am J Pathol2001; 159: 1275–85.
88.
DavidsonG., DonoR., ZellerR.FGF signalling is required for differentiation-induced cytoskeletal reorganisation and formation of actin-based processes by podocytes.J Cell Sci2001; 114: 3359–66.
89.
KhouwI.M., van WachemP.B., PlantingaJ.A., VujaskovicZ., WissinkM.J., de LeijL.F.TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro.Biomaterials1999; 20: 1815–22.
BlomI.E., van DijkA.J., WietenL., DuranK., ItoY., KleijL.In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury.Nephrol Dial Transplant2001; 16: 1139–48.
Gore–HyerE., ShegogueD., MarkiewiczM., LoS., Hazen–MartinD., GreeneE.L.TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells.Am J Physiol Renal Physiol2002; 283: F707–F716.
94.
OatesJ.C., GilkesonG.S.Mediators of injury in lupus nephritis.Curr Opin Rheumatol2002; 14: 498–503.
95.
GauldieJ., KolbM., SimeP.J.A new direction in the pathogenesis of idiopathic pulmonary fibrosis?Respir Res2002; 3: 1.
96.
PiguetP.F., GauldieJ.Inflammation in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med2003; 167: 1037.
97.
GauldieJ.Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis.Am J Respir Crit Care Med2002; 165: 1205–6.
98.
MoriY., MatsuoS., SutohH., ToriyamaT., KawaharaH., HottaN.A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone.Am J Kidney Dis1997; 30: 275–8.
99.
MartinsL.S., RodriguesA.S., CabritaA.N., GuimaraesS.Sclerosing encapsulating peritonitis: A case successfully treated with immunosuppression.Perit Dial Int1999; 19: 478–81.
100.
YamamotoH., NakayamaM., YamamotoR., OtsukaY., TakahashiH., KatoN.Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: A single-center experience in Japan.Adv Perit Dial2002; 18: 135–8.
101.
GarosiG., Di PaoloN.Morphological aspects of peritoneal sclerosis.J Nephrol2001; 14(Suppl 4): S30–8.
102.
WangT., GhenY.G., YeR.G., MaiW.Y., ZhenZ.H., LiH.Q.Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients.Adv Perit Dial1995; 11: 11–14.
103.
DennlerS., GoumansM.J., ten DijkeP.Transforming growth factor beta signal transduction.J Leukoc Biol2002; 71: 731–40.
104.
de BoerW.I., van SchadewijkA., SontJ.K., SharmaH.S., StolkJ., HiemstraP.S.Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease.Am J Respir Crit Care Med1998; 158: 1951–7.
SelmanM., RuizV., CabreraS., SeguraL., RamirezR., BarriosR.TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?Am J Physiol Lung Cell Mol Physiol2000; 279: L562–L574.
107.
KolbM., BonniaudP., GaltT., SimeP.J., KellyM.K., MargettsP.J.Differences in the fibrogenic response after transfer of active TGFbeta1 gene to lungs of a ‘fibrosis-prone’ and ‘resistant’ mouse strain.Am J Respir Cell Mol Physiol2002; 27: 141–50.
108.
el NahasA.M., Muchaneta–KubaraE.C., EssawyM., SoylemezogluO.Renal fibrosis: Insights into pathogenesis and treatment.Int J Biochem Cell Biol1997; 29: 55–62.
109.
BenyonR.C., ArthurM.J.Extracellular matrix degradation and the role of hepatic stellate cells.Semin Liver Dis2001; 21: 373–84.
110.
IredaleJ.P.Hepatic stellate cell behavior during resolution of liver injury.Semin Liver Dis2001; 21: 427–36.
111.
CheginiN., KotseosK., ZhaoY., MaC., McLeanF., DiamondM.P.Expression of matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in serosal tissue of intraperitoneal organs and adhesions.Fertil Steril2001; 76: 1212–19.
112.
MartinJ., YungS., RobsonR.L., SteadmanR., DaviesM.Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells.Perit Dial Int2000; 20: 524–33.
113.
ZhangH.Y., PhanS.H.Inhibition of myofibroblast apoptosis by transforming growth factor beta(1).Am J Respir Cell Mol Biol1999; 21: 658–65.
114.
KirkT.Z., MayesM.D.IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death.Biochem Biophys Res Commun1999; 255: 129–32.
115.
SchuppanD., RuehlM., SomasundaramR., HahnE.G.Matrix as a modulator of hepatic fibrogenesis.Semin Liver Dis2001; 21: 351–72.
116.
GarosiG., Di PaoloN.Peritoneal sclerosis: One or two nosological entities?Semin Dial2000; 13: 297–308.
117.
PollockC.A.Diagnosis and management of encapsulating peritoneal sclerosis.Perit Dial Int2001; 21(Suppl 3): S61–6.
118.
KawaguchiY., KawanishiH., MujaisS., TopleyN., OreopoulosD.G.Encapsulating peritoneal sclerosis: Definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. [Review] [202 refs] Perit Dial Int2000; 20(Suppl 4): S43–55.
119.
GarosiG., Di PaoloN.Inflammation and gross vascular alterations are characteristic histological features of sclerosing peritonitis.Perit Dial Int2001; 21: 417–18.
120.
MactierR.A.The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.Adv Perit Dial2000; 16: 223–8.
121.
FlaniganM., AndersonD., FreemanR.M.Peritoneal di;alysis complicated by fungal peritonitis and peritoneal fibrosis [Letter].Am J Med1984; 76: A113.
122.
HendriksP.M., Ho-dac-PannekeetM.M., van GulikT.M., StruijkD.G., PhoaS.S., SieL.Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics.Perit Dial Int1997; 17: 136–43.
MargettsP.J., GyorffyS., KolbM., YuL., HoffC.M., HolmesC.J.Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol2002; 13: 721–8.
125.
AffleckD.G., BullD.A., BaileyS.H., AlbanilA., ConnorsR., StringhamJ.C.PDGF(BB) increases myocardial production of VEGF: Shift in VEGF mRNA splice variants after direct injection of bFGF, PDGF(BB), and PDGF(AB).J Surg Res2002; 107: 203–9.
126.
MargettsP.J., KolbM., HoffC.M., GauldieJ.The role of angiopoietins in resolution of angiogenesis resulting from adenoviral mediated gene transfer of TGFβ1 or VEGF to the rat peritoneum [Abstract].J Am Soc Nephrol2001; 12: 433A.
127.
LiuW., AhmadS.A., ReinmuthN., ShaheenR.M., JungY.D., FanF.Endothelial cell survival and apoptosis in the tumor vasculature.Apoptosis2000; 5: 323–8.
128.
FlessnerM.F.Changes in the peritoneal interstitium and their effect on peritoneal transport.Perit Dial Int1999; 19(Suppl 2): S77–82.
129.
RippeB., StelinG., HaraldssonB.Computer simulations of peritoneal fluid transport in CAPD.Kidney Int1991; 40: 315–25.
130.
VenturoliD., RippeB.Transport asymmetry in peritoneal dialysis: Application of a serial heteroporous peritoneal membrane model.Am J Physiol Renal Physiol2001; 280: F599–F606.
131.
FlessnerM.F.Net ultrafiltration in peritoneal dialysis: Role of direct fluid absorption into peritoneal tissue.Blood Purif1992; 10: 136–47.
132.
RosengrenB.I., CarlssonO., RippeB.Hyaluronan and peritoneal ultrafiltration: A test of the “filter-cake” hypothesis.Am J Kidney Dis2001; 37: 1277–85.
GunalA.I., DumanS., SenS., UnsalA., TerziogluE., AkcicekF.By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution.J Nephrol2001; 14: 184–9.
135.
ImaiH., NakamotoH., FucshimaR., YamanouchiY., IshidaY., SuzukiH.Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis.Adv Perit Dial2002; 18: 124–30.
